In this study, we found that SCGN can serve as a biomarker for the development and progression of ccRCC, and a better prognosis was demonstrated for patients with high SCGN expression at both the mRNA and protein levels. The gene discussed is SCGN; the disease is nonpapillary renal cell carcinoma.